Cargando…
CDK4/6 inhibition protects normal cells against cancer therapy-induced damage
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236812/ https://www.ncbi.nlm.nih.gov/pubmed/32432028 http://dx.doi.org/10.21037/tcr.2019.12.86 |
| _version_ | 1783536216399937536 |
|---|---|
| author | Boopathi, Ettickan Thangavel, Chellappagounder |
| author_facet | Boopathi, Ettickan Thangavel, Chellappagounder |
| author_sort | Boopathi, Ettickan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7236812 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72368122020-05-19 CDK4/6 inhibition protects normal cells against cancer therapy-induced damage Boopathi, Ettickan Thangavel, Chellappagounder Transl Cancer Res Editorial Commentary AME Publishing Company 2020-02 /pmc/articles/PMC7236812/ /pubmed/32432028 http://dx.doi.org/10.21037/tcr.2019.12.86 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Boopathi, Ettickan Thangavel, Chellappagounder CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title | CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title_full | CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title_fullStr | CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title_full_unstemmed | CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title_short | CDK4/6 inhibition protects normal cells against cancer therapy-induced damage |
| title_sort | cdk4/6 inhibition protects normal cells against cancer therapy-induced damage |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236812/ https://www.ncbi.nlm.nih.gov/pubmed/32432028 http://dx.doi.org/10.21037/tcr.2019.12.86 |
| work_keys_str_mv | AT boopathiettickan cdk46inhibitionprotectsnormalcellsagainstcancertherapyinduceddamage AT thangavelchellappagounder cdk46inhibitionprotectsnormalcellsagainstcancertherapyinduceddamage |